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anBackground: Crystalline/chrysalis structures (CS) are white shiny streaks that can only be seen with
polarized dermatoscopy.Objectives: We sought to estimate the prevalence and assess the clinical significance of CS in melanocytic
and nonmelanocytic lesions.Methods: This was a prospective observational study in which dermatoscopic assessment of lesions was
recorded in consecutive patients examined during a 6-month period. In addition, a data set of biopsy-
proven melanomas was retrospectively analyzed.Results: In all, 11,225 lesions in 881 patients were prospectively examined. Retrospectively, 229
melanomas imaged with polarized dermatoscopy were analyzed. In the prospective data set, a median
of 12.7 lesions (range, 1-54) were evaluated per patient. None of clinically diagnosed Clark nevi (n = 9750,
86.8%) demonstrated CS. Overall, CS were observed in 206 (1.8%) lesions, most commonly dermatofi-
bromas and scars among nonbiopsied lesions. A total of 265 (2.4%) lesions were biopsied, including 20
melanomas and 36 nevi. Among biopsied malignant lesions, CS were most commonly observed in basal
cell carcinoma (47.6%) and invasive melanomas (84.6%). Melanomas were more likely to have CS than
biopsied nevi (odds ratio = 9.7, 95% confidence interval 2.7-34.1). In the retrospective data set, CS were
more commonly observed among invasive melanomas (41%) compared with in situ melanomas (17%)
(odds ratio = 3.4, 95% confidence interval 1.9-6.3, P\.001). The prevalence of CS correlated with increased
melanoma thickness (P = .001).Limitations: Biopsied lesions represent a small percentage of the total number of lesions evaluated.Conclusion: Among biopsied malignant lesions, CS are most commonly observed in basal cell carcinoma
and invasive melanomas and rarely seen in nevi. In melanoma, CS may reflect increased tumor thickness
and progression. ( J Am Acad Dermatol 10.1016/j.jaad.2011.04.039.)
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J AM ACAD DERMATOL1.e2 Balagula et alIdentification ofmelanoma-specific dermatoscopic
structures has improved the ability of clinicians to
recognize melanoma.1-4 In recent years, dermato-
scopes that use cross-polarization technology have
been introduced and are increasingly used.5-7
However, there are clinically relevant and notable
differences between lesion appearance under polar-CAPSULE SUMMARY
d Crystalline/chrysalis structures have been
observed under polarized dermatoscopy
in a variety of lesions including
melanomas, basal cell carcinomas,
dermatofibromas, and Spitz nevi.
d Our study demonstrates the prevalence
of crystalline/chrysalis structures in a
wide spectrum of melanocytic and
nonmelanocytic lesions.
d Crystalline/chrysalis structures may serve
as a diagnostically useful dermatoscopic
feature. In the diagnosis of melanomas
they may serve as a clue to differentiate
them from nevi and identify a subset of
more advanced lesions.ized dermatoscopy (PD) and
non-PD.8,9 In particular, PD
has allowed identification of
new dermatoscopic struc-
tures not previously seen
with non-PD.10 Shiny, bright
white, orthogonally oriented
linear streaks, detected exclu-
sively with PD, represent one
example of such structures
(Fig 1).8,11,12 These bright
white lines are alsometaphor-
ically known as crystalline or
chrysalis structures (CS). The
CS are observed in skin le-
sions with increased amount
of dermal collagen, and are
visible as a result of the inter-
action of polarized light with
the birefringent properties of
collagen.12 The CS are fre-
quently visualized indermatofibromas (DFs) and scars
but can also be seen in basal cell carcinomas (BCC),
Spitz nevi, and melanomas.8,12 The prevalence of CS
among melanocytic neoplasms and among various
nonmelanocytic lesions is currently unknown. More
importantly, the clinical significance of this novel
dermatoscopic structure has not been established.Fig 1. A, Contact nonpolarized image of invasive
irregular globules. B, Polarized contact dermat
crystalline/chrysalis structures (CS) throughout l
network and CS. These two structures are not the
either polarized or nonpolarized dermatoscopy an
polarized dermatoscopy. Whereas some melanom
manifest one or the other.METHODS
The aim of this observational study was to esti-
mate the prevalence of CS seen with PD. The study
consisted of two parts. In the initial prospective
analysis, the lesions of 881 consecutive patients from
the practices of two dermatologists (A. A. M. and R.
P. B.) were evaluated. The two physicians specializemelanoma displaying neg
oscopic image demonstr
esion. Note: This lesion
same. Negative network
d crystalline/chrysalis can
as may manifest both struin pigmented lesions and
are experts in dermatoscopy.
All lesions assessed dermato-
scopicallyaspartof the routine
total body skin examination of
patients who were screened
for skin cancer were included
in this study. Dermatoscopic
evaluations were performed
during the clinical encounter
using a DL-3 dermatoscope
(3Gen, LLC, Dana Point, CA)
and were recorded on a des-
ignated study sheet. For each
lesion, the clinical diagnosis
and the presence or absence
of CS on dermatoscopic eval-
uation were recorded. For le-
sions that were biopsied,
histopathologic diagnosis was
collected. In the retrospec-tive portion of the study, contact PD (DermLite,
3Gen, LLC) images of histopathology-proven mela-
nomas, consecutively recorded between 2004 and
2009, were evaluated for the presence of CS. All
photographswere takenwith a digital camera (Nikon
Coolpix 4500, Nikon USA Inc, Melville, NY). Each
lesionwas analyzed for the presence of the followingative network and
ating conspicuous
has both negative
can be seen with
only be seen with
ctures, others will
Abbreviations used:
BCC: basal cell carcinoma
bFGF: basic fibroblast growth factor
CI: confidence interval
CS: crystalline/chrysalis structures
DFs: dermatofibromas
OR: odds ratio
PD: polarized dermatoscopy
SK: seborrheic keratoses
J AM ACAD DERMATOL Balagula et al 1.e3vascular structures: linear-irregular, dotted, comma,
hairpin, coiled vessels, and pink veil, with the goal of
investigating their potential association with CS. The
presence of two or more vascular structures, exclud-
ing the pink veil, constituted a polymorphous vascu-
lar pattern. Similarly, melanoma thickness and the
presence of histologic regression were extracted
from the pathology reports to investigate their rela-
tionshipwith CS. Because CS are frequently observed
in biopsy scars, melanomas that have been previ-
ously biopsied were specifically excluded from the
retrospective analysis to avoid a misclassification
bias.
Statistical analysis
The goal of the analysis was to determine the
prevalence of CS in lesions of patients undergoing
cutaneous skincancer surveillance. Study lesionswere
classifiedby their clinical diagnosis if not biopsied, and
by the histopathologic diagnosis if biopsied. The
distributional characteristics of all study variables
were examined graphically. Descriptive frequencies,
means, and medians were used to describe the study
variables. For both prospective and retrospective
aspects of the study, the main outcome was the
presence or absence of CS. To evaluate the association
of CS with other study variables, x2 statistics and
logistic regression models were used. All analyses
were performed with Stata SE v.10.1, Stata Corp,
College Station, TX.
Results
In the prospective part of the study, a total of
11,225 lesions were dermatoscopically evaluated in
881 patients. The median number of lesions evalu-
ated per patient was 12.7 (range 1-54). The clinical
diagnoses for nonbiopsied lesions and the histo-
pathologic diagnoses for biopsied lesions are pre-
sented (Tables I and II). The majority (86.8%, n =
9750) of lesions that were not biopsied were clini-
cally diagnosed as Clark nevi followed by seborrheic
keratoses (SK) and solar lentigines (5.8%). Of the
11,225 lesions, 265 (2.4%) were biopsied (Table II).
Nonmelanocytic lesions comprised the majority(n = 209, 78.8%) of biopsied lesions, BCC being the
most common diagnosis (n = 82, 31%). A total of 56
(21.1%) of the 265 biopsied lesions weremelanocytic
neoplasms, 20 of which were melanomas (13 inva-
sive melanoma, 3 in situ melanomas, and 4 cutane-
ous melanoma metastases).
Overall, CS were observed in 206 of the 11,225
study lesions (1.8%). Notably, none of the non-
biopsied Clark nevi and only 3 (0.5%) of SK and
solar lentigines showed CS (Table I). CS were iden-
tified in a much higher proportion of biopsied
lesions than nonbiopsied lesions (33.2% vs 1.1%,
P\.0001). The distribution of CS by histopathologic
diagnosis is presented (Table II). Of note, all of the
biopsied SK were clinically inflamed SK. Overall, CS
were 2.5 times more likely to be observed in malig-
nant compared with benign lesions (odds ratio
[OR] = 2.5, 95% confidence interval [CI] 1.5-4.3). CS
were commonly observed among melanomas (n =
14, 70%); in fact, melanomas were more likely to
harbor CS than biopsied nevi (OR = 9.7, 95% CI 2.7-
34.1) (Fig 2 and Table III). If the nonbiopsied and
biopsied primary melanocytic neoplasms are ana-
lyzed together, excluding melanoma metastases,
these differences become even more striking;
whereas CS were observed in 11 of 16 primary
melanomas (68.8%), CS were observed in only 7 of
10,059 nevi examined (0.07%), 3 of the 7 nevi
showing CS being Spitz nevi. Notably, in the pro-
spective data set, CS were only observed among
invasive melanomas and cutaneous metastases, and
were absent among in situ melanomas. In addition,
CS were more likely to be observed in BCC than all
other biopsied nonmelanocytic lesions (OR = 3.5,
95% CI 1.8-6.7).
In the retrospective part of the study, contact PD
images from a total of 229 melanomas were ana-
lyzed. The data set comprised 119 in situ and 110
invasive melanomas. CS were observed among 45
invasive melanomas (41%) and among 20 in situ
melanomas (17%) (Fig 3). CS were 3.4 times more
likely to be visualized among invasive compared
with in situ melanomas (Table IV). Melanomas
showing CS on dermatoscopy tended to be thicker
on histopathology than those without CS (Table V).
Controlling for the presence of histologic regression,
invasive melanomas were significantly more likely
to have CS (OR = 3.6, 95% CI 1.9-7.0, P \ .001)
compared with in situ melanomas. In contrast, no
significant associationwas observed between CS and
the presence of regression (OR = 1.3, 95% CI 0.7-2.4,
P = .49). Polymorphous vessels were observed
more frequently among invasive melanomas com-
pared with in situ melanomas (P \ .001) (Fig 4).
Interestingly, CS were observed more frequently
Table I. Prevalence of crystalline/chrysalis structures for melanocytic and nonmelanocytic lesions that were not
biopsied
Nonmelanocytic lesions Melanocytic lesions
Crystalline/chrysalis Crystalline/chrysalis
No Yes No Yes
DF 31 (24.8) 94 (75.2) 125 (100) MM Met 8 (100) 0 (0) 8 (100)
SK/solar lentigines 648 (99.5) 3 (0.5) 651 (100) Clark/DN 9750 (100) 0 (0) 9750 (100)
Hemangioma 48 (96) 2 (4) 50 (100) CMN 90 (100) 0 (0) 90 (100)
SCC/Bowen/KA 2 (100) 0 (0) 2 (100) Blue nevus 15 (100) 0 (0) 15 (100)
LPLK 6 (100) 0 (0) 6 (100) IDN 168 (100) 0 (0) 168 (100)
AK 57 (98.3) 1 (1.7) 58 (100) Total 10031 (100) 0 (0) 10031 (100)
Scar 2 (9.5) 19 (90.5) 21 (100)
Otherenonmelanocytic 15 (93.8) 1 (6.3) 16 (100)
Total 809 (87.1) 120 (12.9) 929 (100)
AK, Actinic keratosis; CMN, congenital melanocytic nevus; DF, dermatofibroma; DN, dysplastic nevus; IDN, intradermal nevus; KA,
keratoacanthoma; LPLK, lichen planuslike keratosis; MM Met, malignant melanoma cutaneous metastasis; SCC, squamous cell carcinoma; SK,
seborrheic keratosis.
Table II. Prevalence of crystalline/chrysalis structures by histologic diagnosis for nonmelanocytic and
melanocytic lesions
Nonmelanocytic Melanocytic
Crystalline/chrysalis Crystalline/chrysalis
No Yes No Yes
BCC* 43 (52.4) 39 (47.6) 82 (100) Invasive melanoma 2 (15.4) 11 (84.6) 13 (100)
SK/solar lentigines 27 (84.4) 5 (15.6) 32 (100) MIS 3 (100.0) 0 (0.0) 3 (100)
Hemangioma 1 (100.0) 0 (0.0) 1 (100) MM Met 1 (25.0) 3 (75.0) 4 (100)
SCC/Bowen/KA 35 (87.5) 5 (12.5) 40 (100) Spitz 0 (0.0) 3 (100.0) 3 (100)
LPLK 7 (46.7) 8 (53.3) 15 (100) Clark/DN 19 (95.0) 1 (5.0) 20 (100)
AK 12 (70.6) 5 (29.4) 17 (100) CMN 1 (100.0) 0 (0.0) 1 (100)
Scar 0 (0.0) 2 (100.0) 2 (100) IDN 8 (80.0) 2 (20.0) 10 (100)
Otherenonmelanocytic 19 (95.0) 1 (5.0)y 20 (100) Otheremelanocytic 1 (50.0) 1 (50.0)z 2 (100)
Total 144 (68.9) 65 (31.1) 209 (100) Total 35 (62.5) 21 (37.5) 56 (100)
AK, Actinic keratosis; BCC, basal cell carcinoma; CMN, congenital melanocytic nevus; DN, dysplastic nevus; IDN, intradermal nevus; KA,
keratoacanthoma; LPLK, lichen planuslike keratosis; MIS, melanoma in situ; MM Met, malignant melanoma cutaneous metastasis; SCC,
squamous cell carcinoma; SK, seborrheic keratosis.
*5 BCCs were treated with Mohs and histologically confirmed to be BCCs without initial biopsy performed.
yLesion observed with crystalline/chrysalis structures in this category was normal scalp from bald individual.
zLesion observed with crystalline/chrysalis structures in this category was traumatized nevus.
J AM ACAD DERMATOL1.e4 Balagula et al(63%) among melanomas with polymorphous
vessels on dermatoscopy, and infrequently (12%)
among melanomas without visible dermatoscopi-
cally identified vascular structures; thus, melanomas
with polymorphous vascular pattern were 12.5 times
more likely to display CS on dermatoscopy com-
pared with melanomas lacking discernible vascula-
ture (Table VI).
DISCUSSION
The use of PD has improved visualization of
dermal structures such as collagen and microvascu-
lature.13 The different optical properties of PD have
allowed identification of new dermatoscopicstructures such as shiny, bright white, orthogonally
oriented linear streaks, which have been termed
‘‘crystalline or chrysalis structures.’’12 These struc-
tureswere previously described in a variety of lesions
including melanomas,9,12 Spitz nevi,12 BCC,9 DFs,8,14
scars,12 and porokeratoses. They can also be fre-
quently visualized on the extensively sun-damaged
skin of the bald scalp. It has been postulated that CS
correlate with dermal fibroplasias; the birefringent
properties of the collagen bundles result in rapid
randomization and increased backscatter of polar-
ized light, which makes collagen apparent under
PD.13 The fact that CS are very commonly observed
in biopsy scars and DFs, whose histopathologic
Fig 2. A, Contact nonpolarized image of heavily mela-
nized invasive melanoma (0.85-mm thickness) displaying
negative network, atypical pigment network, peripheral
streaks, and irregular dots and globules. B, Corresponding
polarized contact dermatoscopic image demonstrating
crystalline/chrysalis structures. Inset, Clinical image.
J AM ACAD DERMATOL Balagula et al 1.e5hallmark is dermal fibrosis,14,15 supports this notion.
We have demonstrated that CS are encountered in a
spectrum of melanocytic and nonmelanocytic le-
sions. Probably, all lesions showing CS harbor in-
creased (scarlike) or altered collagen in the dermis.
The clinical significance of CS in melanomas has
not yet been established. Herein, we found that the
presence of CS among melanocytic neoplasms is
highly suggestive of melanoma diagnosis. In our
prospective analysis, among all primary melanocytic
neoplasms, CS were observed in over two thirds of
melanomas, while seen in merely 7 nevi among over
10,000 nevi examined, most frequently in Spitz nevi.
Interestingly, CS were seen only among biopsied
nevi, suggesting that CS are almost only seen among
nevi that are clinically and dermatoscopically equiv-
ocal. Thus, CS may serve as an additional feature that
can help distinguish melanomas from nevi; the
dermatoscopic finding of CS when evaluating a
melanocytic neoplasm should warrant extreme cau-
tion for the diagnosis of melanoma.
In the prospective data set, CS were exclusively
observed in invasive melanomas and in cutaneous
melanoma metastases and were not identified for in
situ melanomas. Similarly, in the retrospective dataset of 229 melanomas, CS were 3.4 times more
commonly encountered among invasive (41%) than
among in situ (17%) melanomas. Melanomas show-
ing CS were also thicker than those without CS.
Although we observed a significant association
between histologic regression changes and CS, our
analyses also demonstrated that the association be-
tween CS and lesion thickness was independent of
the presence of regression. Taken together, these
data suggest that CS is a dermatoscopic finding that
in melanoma signifies a higher likelihood of dermal
invasion and thicker tumors. Indeed, these findings
are in line with those of a recent study that demon-
strated a statistically significant correlation between
the presence of CS and increased depth of
invasion.16
Superficial spreading melanoma begins as in situ
melanoma and progresses by dermal invasion with
subsequent metastases. The functional interaction of
melanoma cells with surrounding neoplastic cells,
tumoral stoma, inflammatory milieu, and growth
factors is critical, and fibroblasts serve as the major
source of extracellular matrix and contribute to
melanoma progression.17 Basic fibroblast growth
factor (bFGF) appears to play a critical role in the
ability of melanoma cells to invade and proliferate in
the papillary dermis.18 In primary invasive melano-
mas, the greatest expression of bFGF is along the
advancing front of the neoplasm, adjacent to the
fibrotic changes in the dermis, and it is usually not
detectable in definitive in situ lesions.19 Melanocyte-
fibroblast interactions and tumor-induced collagen
turn-over appear to play a critical role in melanoma
evolution through both radial and vertical growth
phases.20 Melanocytes in the radial and early vertical
growth phases have been shown to induce de novo
type I collagen synthesis by fibroblasts juxtaposed to
microinvasive nests in the papillary dermis; staining
with Sirius red can identify tightly woven collagen
bundles encircling these melanoma nests at the
dermoepidermal junction.21 In contrast, this has not
been demonstrated in dysplastic nevi.21 Evidence of
stromal remodeling can also be identified with
reflectance confocal microscopy by visualizing bun-
dles of collagen fibers that histopathologically cor-
respond to fibroplasia and to regression structures
on dermatoscopy.22,23 Type I collagen with extra-
cellular matrix glycoproteins, such as tenascin C and
fibronectin, have been shown to facilitate dermal
invasion during the more advanced vertical growth
phase by forming tubular channels that ensheath and
isolate invading melanoma cells.24 Based on the
available preclinical data, we hypothesize that CS
may reflect de novo synthesis or remodeling of type I
collagen in the papillary dermis, signifying changes
Table III. Association between lesion diagnosis and crystalline/chrysalis structures for histologically diagnosed
melanomas and basal cell carcinomas
Crystalline/chrysalis structures Crystalline/chrysalis structures
Yes No Yes No
Melanoma 14 (70.0) 6 (30.0) Basal cell carcinoma 39 (60.0) 43 (30.1)
All other biopsied
melanocytic lesions
7 (19.4) 29 (80.6) All other biopsied
nonmelanocytic lesions
26 (40.0) 100 (69.9)
Total 21 (100) 35 (100) Total 65 (100) 143 (100)
OR = 9.7; 95% CI 2.7-34.1 OR = 3.5; 95% CI 1.8-6.7
CI, Confidence interval; OR, odds ratio.
Fig 3. Polarized contact dermatoscopic image of hypo-
melanotic melanoma in situ with crystalline/chrysalis
structures. Inset, Clinical image.
Table IV. Association between crystalline/chrysalis
structures for in situ and invasive melanoma among
retrospectively analyzed lesions
PCD
MIS Invasive
Crystalline/
chrysalis
Absent 99 (83.2) 65 (59.1) 164 (71.6)
Present 20 (16.8) 45 (40.9) 65 (28.4)
Total 119 (100) 110 (100) 229 (100)
OR = 3.4 (CI 1.9-6.3), P\ .001
MIS, Melanoma in situ, OR, odds ratio; PCD, polarized contact
dermatoscopy.
Table V. Differences in tumor thickness and
presence of regression by presence or absence of
crystalline/chrysalis structures for polarized contact
dermatoscopy among retrospectively analyzed
lesions
PCD
Crystalline/chrysalis
P valuePresent Absent
Thickness, mean, (SD)* 0.68 (0.50) 0.43 (0.28) .001
Thickness, mediany 0.55 0.39 .001
Regression n (%) n (%)
Absent 38 (53.5) 121 (67.2) .04
Present 33 (46.5) 59 (32.8)
PCD, Polarized contact dermatoscopy.
*Based on Student t test.
yBased on Wilcoxon sign rank test.
Fig 4. Polarized contact dermatoscopic image of amela-
notic melanoma with crystalline/chrysalis structures and
polymorphous vessels.
J AM ACAD DERMATOL1.e6 Balagula et alin the extracellular matrix induced by tumor pro-
gression and dermal invasion.23
Our retrospective analysis revealed that the pres-
ence of CS in melanomas was frequently associated
with polymorphous vascular pattern (OR = 12.5)
(Fig 5). Vascular structures were also significantly
increased in invasive as compared with in situ
melanomas. These findings support the preclinical
evidence of intricate relationship between tumor-
induced stromal response and neoangiogenesis.
Early melanoma development is characterized by
an inflammatory cell infiltrate including mast cells
that secrete matrix metalloproteinases, which releasematrix-sequestered vascular endothelial growth fac-
tor, thereby enhancing angiogenesis.25 Subsequent
influx of macrophages augments angiogenesis via
the release of proangiogenic factors such as
interleukin-8, vascular endothelial growth factor,
and bFGF.25 bFGF expression is positively correlated
with increased intratumoral microvascular density.26
In early melanomas, incompletely formed capillaries
Table VI. Association between crystalline/chrysalis structures and presence of vessels for lesions imaged with
polarized contact dermatoscopy among retrospectively analyzed lesions
Vascular structures
None 1 Polymorphous pattern Total
Crystalline/chrysalis Absent 117 (88.0) 26 (66.7) 21 (36.8) 164 (71.6)
Present 16 (12.0) 13 (33.3) 36 (63.2) 65 (28.4)
Total 133 (100) 39 (100) 57 (100) 229 (100)
Referent 3.6 (1.6-8.5), P = .003 12.5 (5.9-26.5), P\ .001
Fig 5. A, Contact nonpolarized image of invasive mela-
noma without negative network that displays atypical
pigment network and polymorphous vascular pattern.
B, Corresponding polarized contact dermatoscopic image
of invasive melanoma (0.83-mm thickness) with crystal-
line/chrysalis structures, pink veil, and polymorphous
vasculature. Inset, Clinical image.
J AM ACAD DERMATOL Balagula et al 1.e7can be visualized, and vascular density correlates
with increased depth of invasion.27,28 Both degrada-
tion and synthesis of new collagen fibrils are neces-
sary for the development of the vascular network.20
De novo type I collagen synthesis has been shown to
serve as an angiogenic trigger in early melanoma,21
with vascular network forming in the papillary der-
mis, where high levels of collagen expression are
found.21
CS have been previously identified in BCC12 but
their prevalence and clinical significance are not
known. In our study, CS were observed in approx-
imately 48% of BCCs. Thus, CS may serve as an
additional dermatoscopic feature in their diagnosis.A fibroplastic stroma is typical of BCC, particularly
the morpheaform and infiltrative types,29 but further
studies may demonstrate different rates of CS across
the various BCC histopathologic subtypes.
CS are very frequently observed in DFs.8,10 In our
study, they were seen in 75% of DFs and likely reflect
the pronounced dermal fibrosis.30 Increased preva-
lence of CS among biopsy-proven lichen planuslike
keratoses (53.3%) was also noted, in contrast to their
low prevalence among clinically diagnosed SK/solar
lentigines (0.5%). As lichen planuslike keratosis
represent SK/solar lentigines that have undergone
regression,31,32 the dermatoscopically observed CS
probably reflect the papillary dermal fibrosis.
The main limitation of our study is that only a
small percentage of lesions evaluated were biopsied.
However, with the exception of cutaneous mela-
noma metastases, SCC/Bowen/keratoacanthoma,
and actinic keratoses, the nonbiopsied lesions were
deemed to be completely benign in appearance (eg,
SK) and a confirmatory biopsy specimen was not
necessary. Secondly, CS incidence was analyzed
among nonbiopsied lesions whereby diagnosis was
based solely on clinical and dermatoscopic assess-
ments. This was done to avoid a selection bias
intrinsic to studies that include only biopsied lesions.
Of note, many of the lesions with CS were biopsied
(46 times more frequently than lesions without
CS), allowing histopathologic confirmation of the
diagnosis. Our retrospective analysis also included
some PD photographs taken with a flash, which
may partially obscure the appearance of CS and
potentially underestimate their incidence among
melanomas.
In conclusion, we have systematically demon-
strated the incidence of CS among melanocytic and
nonmelanocytic lesions. CS may serve as a diagnos-
tically useful dermatoscopic feature. They may be
particularly important in the diagnosis of melanomas
and serve as a clue to differentiate them from nevi
and identify a subset of more advanced lesions.
Like any other dermatoscopic clue, CS should be
interpreted in the context of other dermatoscopic
structures and the overall pattern. The precise
J AM ACAD DERMATOL1.e8 Balagula et alhistopathologic correlates of CS need to be further
studied. Nevertheless, our study reinforces the idea
that dermatoscopy can be used as a powerful
research tool that provides further insights into our
understanding of malignant and benign neoplasms.
Because morphologic features reflect underlying
biological changes that can be correlated with spe-
cific molecular and cellular-level findings, dermatos-
copy can serve as an ideal instrument to facilitate
transitional research between the clinic and basic
science investigations.
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